Open AccessIs the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?
Author(s) -
Sanjay Kaul
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.022537
Subject(s) - empagliflozin , medicine , type 2 diabetes mellitus , milestone , diabetes mellitus , holy grail , type 2 diabetes , randomized controlled trial , surgery , intensive care medicine , endocrinology , archaeology , world wide web , computer science , history
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom